SA is a feasible alternative to intubated GA for VATS spontaneous ventilation anesthesia, potentially reducing procedural time and LOS without raising complication risk. Applicability to U.S. practice requires caution, given oncologic standards and lower adoption. Prospective randomized trials with standardized endpoints remain necessary.
Xu et al. (Mon,) studied this question.